Re: Second response from Hawk on Feb. licenses/Billwilke
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: Second response from Hawk on Feb. licenses/Billwilke
It appears PTSC has decided that they will not discuss the MMP even in a general way to shareholders. The MMP is the only reason any of us are here. Shareholders understand that PTSC can't provide specific details of settlements, but that should not stop them from talking about general information regarding the MMP. If some of our general questions are not answered, then it would appear that PTSC is purposely keeping us in the dark.
All the best,
Steve
3 Recommendations
Loading...
Loading...
11
Apr 30, 2008 09:49AM
Apr 30, 2008 09:56AM
7
Apr 30, 2008 10:51AM
1
Apr 30, 2008 11:05AM
Apr 30, 2008 11:15AM
8
Apr 30, 2008 11:41AM
2
Apr 30, 2008 12:35PM
3
Apr 30, 2008 12:38PM
Apr 30, 2008 12:56PM
2
Apr 30, 2008 12:57PM
2
Apr 30, 2008 01:57PM
New Message
Please
login
to post a reply